Published: October 25th 2024 | Updated: October 29th 2024
Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf
Published: October 26th 2024 | Updated: October 29th 2024
Veterans’ Experience With Infliximab Biosimilars for IBD Treatment
Published: October 20th 2024 | Updated: October 29th 2024
Addressing Hesitance in Biosimilar Adoption
Published: October 19th 2024 | Updated: October 29th 2024
Phase 3 Study Reports Similar Efficacy Between SB17, Stelara in Psoriasis
Published: October 15th 2024 | Updated: October 29th 2024
Eye on Pharma: Aflibercept Legal Drama; PBM, Humira Biosimilars; Denosumab Regulatory Review
Published: October 15th 2024 | Updated: October 29th 2024
Blue Shield of California Lowers Humira Biosimilar Costs, Challenges PBM Pricing